Schedule 13D ownership disclosure
Mirati Therapeutics Inc
Security class unavailable · CUSIP: 60468T105
Event date: 2019-07-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-19-198165
- Form type
- SC 13D
- Filer
- Boxer Capital, LLC
- CIK
- CIK 1465837
- Filed
- Jul 19, 2019
- Reporting period
- Jul 18, 2019
- Description
- Schedule 13D beneficial ownership